Margot Schoenborn

Margot Schoenborn serves as Chief Executive Officer and a member of the Board of Directors. She is responsible for leading corporate strategy and oversight of all commercial and corporate functions, while partnering with the Company’s President & CMO and Chief Scientific Officer to enable OmniSeqto realize the potential of its genomic testing and next-generation sequencing (NGS) assays in clinical and research settings.